Focusing on IFITMs expressed in target cells, the work of Foster et al. revealed that transmitted/founder (T/F) variants of HIV-1, isolated early in infection, exhibited greater resistance to IFITM2 and IFITM3 restriction compared to viral variants isolated during the chronic phase of infection [37]. This evidence concerns the gene IFITM3 and infection.